2001
DOI: 10.1128/aac.45.3.949-951.2001
|View full text |Cite
|
Sign up to set email alerts
|

Comparison of Efficacies of Cysteine Protease Inhibitors against Five Strains of Plasmodium falciparum

Abstract: Falcipain-2, a cysteine protease and essential hemoglobinase of Plasmodium falciparum, is a potential antimalarial drug target. We compared the falcipain-2 sequences and sensitivities to cysteine protease inhibitors of five parasite strains that differ markedly in sensitivity to established antimalarial drugs. The sequence of falcipain-2 was highly conserved, and the sensitivities of all of the strains to falcipain-2 inhibitors were very similar. Thus, cross-resistance between cysteine protease inhibitors and … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
71
0

Year Published

2004
2004
2017
2017

Publication Types

Select...
6
2

Relationship

4
4

Authors

Journals

citations
Cited by 88 publications
(71 citation statements)
references
References 15 publications
0
71
0
Order By: Relevance
“…Over the past years the development of small molecule inhibitors against Pf falcipains has received a lot of attention by both the pharmaceutical industry and the medicinal chemistry community. Indeed, most studies in this area have shown that falcipain inhibitors prevent hemoglobin hydrolysis, block parasite development and cure murine malaria [11][12][13]. Moreover, the combination of high-throughput screening, molecular modeling methods and the availability of X-ray structures of falcipains has contributed to the discovery of potent inhibitors able to inactivate these Pf enzymes in a reversible or irreversible manner [7,14].…”
Section: Introductionmentioning
confidence: 99%
“…Over the past years the development of small molecule inhibitors against Pf falcipains has received a lot of attention by both the pharmaceutical industry and the medicinal chemistry community. Indeed, most studies in this area have shown that falcipain inhibitors prevent hemoglobin hydrolysis, block parasite development and cure murine malaria [11][12][13]. Moreover, the combination of high-throughput screening, molecular modeling methods and the availability of X-ray structures of falcipains has contributed to the discovery of potent inhibitors able to inactivate these Pf enzymes in a reversible or irreversible manner [7,14].…”
Section: Introductionmentioning
confidence: 99%
“…Structureguided approaches have already proven indispensable in the design of potent and highly selective inhibitors against the closest known structural homolog of falcipain-2, cruzipain (cruzain), from T. cruzi (the causative agent of Chagas disease) (46,47,61,62). An experimental cure for Chagas disease in mice using optimized vinyl-sulfone-derivatized pseudopeptides has been reported (63), and similar vinyl-sulfone inhibitors have shown marked antimalarial effects in mice (with up to a 40% cure rate after 4 days of oral administration) (64) and broad activity across multiple P. falciparum strains (65).…”
Section: Structural Determinants Of Protein Folding and Hemoglobinmentioning
confidence: 99%
“…Drug resistance might also develop by other mechanisms, including increases in target enzyme expression and diminished intracellular accumulation of an inhibitor. Earlier, we evaluated five strains of P. falciparum, which vary greatly in their sensitivities to established antimalarial drugs, and showed no differences in their sensitivities to cysteine protease inhibitors (17). However, the likelihood of selection of resistance of P. falciparum to protease inhibitors has not previously been explored.…”
mentioning
confidence: 99%